期刊
GENES CHROMOSOMES & CANCER
卷 61, 期 6, 页码 314-321出版社
WILEY
DOI: 10.1002/gcc.23015
关键词
colorectal carcinoma; endometrial carcinoma; immune checkpoint inhibition; Lynch syndrome; microsatellite instability (MSI); mismatch repair; mismatch repair deficiency (d-MMR); PD-1
资金
- Mayo Clinic
The mismatch repair system is crucial for maintaining genomic integrity, with deficiencies leading to hypermutability and microsatellite instability. Detection of these deficiencies is used for diagnostic, predictive, and prognostic purposes. Microsatellite instability can be evaluated through PCR or immunohistochemistry to assess mismatch repair function.
The mismatch repair system is a major pathway that functions in the maintenance of genomic integrity. It is involved in mitotic and meiotic recombination, apoptosis, immunoglobulin gene rearrangement, somatic hypermutation, and other processes. Deficiencies in mismatch repair give rise to hypermutability and the phenomenon called microsatellite instability. Detection of deficient mismatch repair function or microsatellite instability is used diagnostically, predictively, and prognostically. Specifically, deficient mismatch repair function is used for screening of Lynch syndrome, determining patients who are likely to respond to immune checkpoint inhibition, and to contributes to an understanding of which cancer patients may pursue a more aggressive clinical course. Microsatellite instability can be evaluated directly by polymerase chain reaction (PCR) or indirectly by assessment of mismatch repair protein expression using immunohistochemistry (IHC), and mismatch repair function using next-generation sequencing assays which evaluates homopolymer indels. In this article, we provide a concise practical review on mismatch repair deficiency (MMR-d)/microsatellite instability (MSI), focusing on clinical testing, different testing methods, interpretation of findings, the predictive, and prognostic utility of MSI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据